                               SEQUENCE LISTING

<110> PRESIDENT AND FELLOWS OF HARVARD COLLEGE
 
<120> METHODS OF GENETIC MODIFICATION OF A CELL

<130> 010498.01050/WO

<140>
<141>

<150> 62/462,409
<151> 2017-02-23

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gagaaaataa tgaatgtcaa                                                   20


<210> 2
<211> 90
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
cgcagcaggc cagcgccaac acaaaggtca gggccaggaa ggccacagag tgactctgtc       60

ctgccatcac tgtcaggtgt tgccacagtg                                        90


<210> 3
<211> 90
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
cgcagcaggc cagcgccaac acaaaggtca gggccaggaa ggccacagaa gtactctgtc       60

ctgccatcac tgtcaggtgt tgccacagtg                                        90


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
cctgacagtg atggcaggac                                                   20


<210> 5
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
tggtggtgac cctgtgga                                                     18


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
aggaagaagg aacgcaagaa                                                   20


